Susan Mahony, Director at Axsome Therapeutics, Inc. (AXSM), sold 600 shares at $237.21 ($145K) on 2026-06-09, disclosed to the SEC on 2026-06-10.
Scheduled sale ($145k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $237.21 | 300 | $71K | 49.1% |
| 2 | $246.18 | 300 | $74K | 50.9% |
| Total | $241.69 avg | 600 | $145K | 100% |
| Filing → |
| LLY | SELL | 2016-12-19 | $2.9M | — | Filing → |
| LLY | SELL | 2015-07-29 | $2.1M | — | Filing → |
| LLY | SELL | 2014-07-30 | $131K | — | Filing → |